Systematic Review and Principal Components Analysis of the Immunogenicity of Adalimumab

ConclusionsFuture studies that evaluate the patient-, product-, and disease-related factors behind the immunogenicity of adalimumab are required because the evidence published so far does not completely explain the temporal increase in immunogenicity rates detected in this analysis.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research